Sanara MedTech Inc. (SMTI)
USD 31.79
(-6.47%)
USD 31.79
(-6.47%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.21 Million USD | 37.34% |
| 2022 | -12.23 Million USD | -65.84% |
| 2021 | -7.37 Million USD | -47.39% |
| 2020 | -5 Million USD | -90.29% |
| 2019 | -2.63 Million USD | -424.06% |
| 2018 | -501.86 Thousand USD | -516.67% |
| 2017 | 120.44 Thousand USD | 144.26% |
| 2016 | -272.13 Thousand USD | 71.8% |
| 2015 | -964.98 Thousand USD | 53.21% |
| 2014 | -2.06 Million USD | 29.57% |
| 2013 | -2.92 Million USD | 45.96% |
| 2012 | -5.41 Million USD | -8.05% |
| 2011 | -5.01 Million USD | -63.35% |
| 2010 | -3.07 Million USD | -66.67% |
| 2009 | -1.84 Million USD | -4.74% |
| 2008 | -1.75 Million USD | -333.47% |
| 2007 | -405.73 Thousand USD | 16.84% |
| 2006 | -487.88 Thousand USD | 34.14% |
| 2005 | -740.82 Thousand USD | 87.91% |
| 2004 | -6.12 Million USD | 0.0% |
| 2001 | -1.44 Million USD | -42.81% |
| 2000 | -1.01 Million USD | -44.4% |
| 1999 | -702.19 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.59 Million USD | 26.76% |
| 2024 Q2 | -2.89 Million USD | -80.6% |
| 2023 Q3 | -906.65 Thousand USD | 51.42% |
| 2023 Q4 | -2.18 Million USD | -140.55% |
| 2023 FY | -7.66 Million USD | 37.34% |
| 2023 Q2 | -1.86 Million USD | -11.81% |
| 2023 Q1 | -1.66 Million USD | 44.58% |
| 2022 Q1 | -2.77 Million USD | 18.62% |
| 2022 Q2 | -3.19 Million USD | -15.04% |
| 2022 Q4 | -3.01 Million USD | 3.55% |
| 2022 Q3 | -3.12 Million USD | 2.25% |
| 2022 FY | -12.23 Million USD | -65.84% |
| 2021 Q2 | -1.02 Million USD | 5.29% |
| 2021 FY | -7.37 Million USD | -47.39% |
| 2021 Q3 | -1.85 Million USD | -80.67% |
| 2021 Q4 | -3.41 Million USD | -84.05% |
| 2021 Q1 | -1.08 Million USD | -27.17% |
| 2020 Q3 | -1.3 Million USD | -21.04% |
| 2020 Q2 | -1.07 Million USD | 39.88% |
| 2020 Q4 | -852.05 Thousand USD | 34.8% |
| 2020 FY | -5 Million USD | -90.29% |
| 2020 Q1 | -1.79 Million USD | -22.79% |
| 2019 Q2 | -323.13 Thousand USD | -105.62% |
| 2019 FY | -2.63 Million USD | -424.06% |
| 2019 Q4 | -1.46 Million USD | -83.46% |
| 2019 Q3 | -797.21 Thousand USD | -146.72% |
| 2019 Q1 | -157.14 Thousand USD | 66.39% |
| 2018 Q3 | -131.99 Thousand USD | -526.07% |
| 2018 Q2 | 30.98 Thousand USD | -53.56% |
| 2018 Q1 | 66.7 Thousand USD | 340.29% |
| 2018 FY | -501.86 Thousand USD | -516.67% |
| 2018 Q4 | -467.55 Thousand USD | -254.22% |
| 2017 Q4 | -27.76 Thousand USD | 3.52% |
| 2017 Q1 | 58.25 Thousand USD | -78.94% |
| 2017 Q3 | -28.77 Thousand USD | -124.24% |
| 2017 Q2 | 118.72 Thousand USD | 103.78% |
| 2017 FY | 120.44 Thousand USD | 144.26% |
| 2016 Q3 | 216.15 Thousand USD | 123.92% |
| 2016 Q1 | 138.86 Thousand USD | 135.26% |
| 2016 Q2 | -903.8 Thousand USD | -750.85% |
| 2016 FY | -272.13 Thousand USD | 71.8% |
| 2016 Q4 | 276.65 Thousand USD | 27.99% |
| 2015 Q2 | -343.19 Thousand USD | -257.38% |
| 2015 Q3 | -131.9 Thousand USD | 61.56% |
| 2015 FY | -964.98 Thousand USD | 53.21% |
| 2015 Q1 | -96.03 Thousand USD | 61.54% |
| 2015 Q4 | -393.85 Thousand USD | -198.58% |
| 2014 Q4 | -249.66 Thousand USD | 61.44% |
| 2014 Q3 | -647.48 Thousand USD | 13.87% |
| 2014 Q2 | -751.74 Thousand USD | -81.74% |
| 2014 Q1 | -413.63 Thousand USD | 78.64% |
| 2014 FY | -2.06 Million USD | 29.57% |
| 2013 Q3 | -331.42 Thousand USD | -20.25% |
| 2013 Q2 | -275.6 Thousand USD | 31.63% |
| 2013 Q1 | -403.09 Thousand USD | 86.67% |
| 2013 FY | -2.92 Million USD | 45.96% |
| 2013 Q4 | -1.93 Million USD | -484.34% |
| 2012 FY | -5.41 Million USD | -8.05% |
| 2012 Q4 | -3.02 Million USD | -73.84% |
| 2012 Q3 | -1.73 Million USD | -301.13% |
| 2012 Q2 | -433.68 Thousand USD | -96.19% |
| 2012 Q1 | -221.05 Thousand USD | 93.1% |
| 2011 Q1 | -476.05 Thousand USD | 54.2% |
| 2011 FY | -5.01 Million USD | -63.35% |
| 2011 Q4 | -3.2 Million USD | -326.03% |
| 2011 Q3 | -751.84 Thousand USD | 2.13% |
| 2011 Q2 | -768.19 Thousand USD | -61.37% |
| 2010 FY | -3.07 Million USD | -66.67% |
| 2010 Q1 | -459.49 Thousand USD | 49.26% |
| 2010 Q2 | -618.91 Thousand USD | -34.7% |
| 2010 Q3 | -951.64 Thousand USD | -53.76% |
| 2010 Q4 | -1.03 Million USD | -9.21% |
| 2009 Q2 | -249.58 Thousand USD | 47.15% |
| 2009 Q3 | -236.86 Thousand USD | 5.1% |
| 2009 Q1 | -472.25 Thousand USD | 42.86% |
| 2009 Q4 | -905.57 Thousand USD | -282.32% |
| 2009 FY | -1.84 Million USD | -4.74% |
| 2008 Q4 | -826.44 Thousand USD | -129.75% |
| 2008 Q2 | -216.01 Thousand USD | 39.42% |
| 2008 Q1 | -356.56 Thousand USD | -79.55% |
| 2008 FY | -1.75 Million USD | -333.47% |
| 2008 Q3 | -359.72 Thousand USD | -66.52% |
| 2007 Q2 | 27.49 Thousand USD | 118.94% |
| 2007 FY | -405.73 Thousand USD | 16.84% |
| 2007 Q4 | -198.58 Thousand USD | -121.94% |
| 2007 Q3 | -89.47 Thousand USD | -425.49% |
| 2007 Q1 | -145.16 Thousand USD | 5.69% |
| 2006 Q2 | -117.09 Thousand USD | -2.4% |
| 2006 Q1 | -114.34 Thousand USD | 7.43% |
| 2006 Q3 | -105.03 Thousand USD | 10.3% |
| 2006 Q4 | -153.91 Thousand USD | -46.54% |
| 2006 FY | -487.88 Thousand USD | 34.14% |
| 2005 FY | -740.82 Thousand USD | 87.91% |
| 2005 Q4 | -123.52 Thousand USD | -10.28% |
| 2005 Q2 | -326.71 Thousand USD | -92.64% |
| 2005 Q1 | -169.59 Thousand USD | -166.33% |
| 2005 Q3 | -112.01 Thousand USD | 65.71% |
| 2004 Q4 | -63.68 Thousand USD | 98.92% |
| 2004 FY | -6.12 Million USD | 0.0% |
| 2004 Q3 | -5.88 Million USD | -5556.46% |
| 2004 Q2 | -104.06 Thousand USD | -39.9% |
| 2004 Q1 | -74.38 Thousand USD | 0.0% |
| 2002 Q1 | -303.48 Thousand USD | 71.36% |
| 2001 Q4 | -1.05 Million USD | -280.22% |
| 2001 Q1 | 34.14 Thousand USD | 107.17% |
| 2001 FY | -1.44 Million USD | -42.81% |
| 2001 Q3 | -278.71 Thousand USD | -145.77% |
| 2001 Q2 | -113.4 Thousand USD | -432.15% |
| 2000 FY | -1.01 Million USD | -44.4% |
| 2000 Q2 | -291.08 Thousand USD | -2333.98% |
| 2000 Q3 | -160.48 Thousand USD | 44.87% |
| 2000 Q1 | 13.03 Thousand USD | 0.0% |
| 2000 Q4 | -476.03 Thousand USD | -196.62% |
| 1999 FY | -702.19 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 92.691% |
| AngioDynamics, Inc. | -97.71 Million USD | 95.686% |
| AtriCure, Inc. | -26.68 Million USD | 84.203% |
| Avinger, Inc. | -16.63 Million USD | 74.661% |
| Azenta, Inc. | -73.12 Million USD | 94.236% |
| BioLife Solutions, Inc. | -70.82 Million USD | 94.048% |
| The Cooper Companies, Inc. | 533.1 Million USD | 100.791% |
| Daxor Corporation | -177.07 Thousand USD | -2280.434% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 72.107% |
| Femasys Inc. | -14.5 Million USD | 70.947% |
| GlucoTrack, Inc. | -7.1 Million USD | 40.665% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 322.553% |
| Hologic, Inc. | 882.6 Million USD | 100.478% |
| ICU Medical, Inc. | 22.82 Million USD | 118.467% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.239% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 58.957% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 111.367% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 38.916% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 38.916% |
| Masimo Corporation | 136.5 Million USD | 103.088% |
| Microbot Medical Inc. | -9.85 Million USD | 57.228% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 128.723% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 103.401% |
| Nephros, Inc. | -1.59 Million USD | -164.605% |
| NovoCure Limited | -232.87 Million USD | 98.19% |
| NEXGEL, Inc. | -3.47 Million USD | -21.23% |
| NEXGEL, Inc. | -3.47 Million USD | -21.23% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 95.9% |
| OraSure Technologies, Inc. | 54.07 Million USD | 107.794% |
| Pro-Dex, Inc. | 7.17 Million USD | 158.764% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 90.326% |
| Predictive Oncology Inc. | -13.92 Million USD | 69.722% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -54.722% |
| QuidelOrtho Corporation | 139.1 Million USD | 103.03% |
| Repligen Corporation | 54.57 Million USD | 107.723% |
| STAAR Surgical Company | 28.09 Million USD | 115.002% |
| Sharps Technology, Inc. | -10.12 Million USD | 58.376% |
| Utah Medical Products, Inc. | 16.77 Million USD | 125.125% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 95.041% |
| Jin Medical International Ltd. | 2.86 Million USD | 247.01% |